With the advent of longer acting wet AMD treatments, patients with unilateral wet AMD whose fellow eyes are monitored for progression from intermediate AMD to wet AMD during injection visits are at increased risk of experiencing undetected disease progression because more durable treatments lead to a reduced number of office visits.
Miguel Busquets, MD of Retina Associates of Kentucky discusses how ForeseeHome for fellow eye AMD progression can help.
